|
|
The protective effect of Endocan on inflammation in endotoxin-induced acute lung injury in mice |
ZHANG Xiaolong1, WU Haiya1, CHEN Jie1, WU Chengyun2. |
1.Department of Anesthesia and Critical Care, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027; 2.Department of Respiratory Medicine, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027 |
|
Cite this article: |
ZHANG Xiaolong,WU Haiya,CHEN Jie, et al. The protective effect of Endocan on inflammation in endotoxin-induced acute lung injury in mice[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2018, 48(9): 636-640.
|
|
Abstract Objective: To investigate the effect of Endocan on lipopolysaccharide (LPS) induced acute lung injury (ALI). Methods: LPS was used to construct C57BL/6 mice ALI model by aerosol inhalation for 30 min, and Endocan was injected intraperitoneally at 30 min prior to LPS exposure. Mice in control group were treated with normal saline at an equal volume. The mice were sacrificed 24 h after aerosol inhalation. The ratio of lung wet weight to dry weight (W/D) was measured to assess the extent of pulmonary edema. Myeloperoxidase (MPO) activity in lung tissues was measured to determine Neutrophil infiltration. The level of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α) and interleukins-6 (IL-6) in bronchoalveolar lavage fluid (BALF) were detected by ELISA. The ultrastructural changes were visualized by electron microscope. Results: Compared with the control group, the lung W/D, MPO activity and the concentrations of TNF-α, IL-6 and ICAM-1 were dramatically increased in LPS group [W/D: 5.62±0.95 vs. 4.08±0.76, MPO (U/g): 2.71±0.59 vs. 1.39±0.28, TNF-α (pg/mL): 140.36±10.01 vs. 79.65±6.23, IL-6 (pg/mL): 156.54±17.82 vs. 50.11±6.02, ICAM-1 (pg/mL): 107.05±13.92 vs. 57.31±8.02, P<0.01] which could be relieved by Endocan treatment [W/D: 4.38±0.47 vs. 5.62±0.95, MPO (U/g): 1.84±0.42 vs. 2.71±0.59, TNF-α (pg/mL): 113.07±8.49 vs. 140.36±10.01, IL-6 (pg/mL): 123.22±12.80 vs. 156.54±17.82, ICAM-1 (pg/mL): 89.44±10.92 vs. 107.05±13.92, P<0.01]. Electron microscope data showed obvious ultrastructure injury induced by LPS, which was greatly attenuated in Endocan group. Conclusion: Endocan can suppress inflammatory response in endotoxin-induced acute lung injury, which suggests that Endcan may be a potential protective agent for ALI.
|
Received: 07 November 2017
|
|
|
|
|
[1] BELLANI G, LAFFEY J G, PHAM T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 coun-tries[J]. JAMA, 2016, 315(8): 788-800.
[2] XIANG B, CHEN L, WANG X, et al. Transplantation of menstrual blood-derived mesenchymal stem cells promotes the repair of LPS-induced acute lung injury[J]. Int J Mol Sci, 2017, 18(4): E689.
[3] ZHAO J, YU H, LIU Y, et al. Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 2016, 311(5): L868-L880.
[4] 刘松桥, 邱海波. 急性呼吸窘迫综合征诊治进展[J]. 中华急诊医学杂志, 2014, 23(3): 248-251.
[5] 洪辉华, 杨珺超, 高润娣, 等. 芪冬活血饮对急性肺损伤大鼠TLR4/NF-κB炎症信号通路的影响[J]. 温州医科大学学报, 2015, 45(5): 332-337.
[6] LEE W, KU S K, KIM S W, et al. Endocan elicits severe vascular inflammatory responses in vitro and in vivo[J]. J Cell Physiol, 2014, 229(5): 620-630.
[7] TYAGI A, SETHI A K, GIROTRA G, et al. The microcirculation in sepsis[J]. Indian J Anaesth, 2009, 53(3): 281-293.
[8] LEE W L, SLUTSKY A S. Sepsis and endothelial permea-bility[J]. N Engl J Med, 2010, 363(7): 689-691.
[9] XU H, YE X, STEINBERG H, et al. Selective blockade of endothelial NF-kappaB pathway differentially affects systemic inflammation and multiple organ dysfunction and injury in septic mice[J]. J Pathol, 2010, 220(4): 490-498.
[10] KECHAGIA M, PAPASSOTIRIOU I, GOURGOULIANIS K I. Endocan and the respiratory system: a review[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11:3179-3187.
[11] BÉCHARD D, SCHERPEREEL A, HAMMAD H, et al. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1[J]. J Immunol, 2001, 167 (6): 3099-3106.
[12] KANG Y H, JI N Y, HAN S R, et al. ESM-1 regulates cell growth and metastatic process through activation of NF-κB in colorectal cancer[J]. Cell Signal, 2012, 24(10): 1940-1949.
[13] SARRAZIN S, LYON M, DEAKIN J A, et al. Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan[J]. Glycobiology, 2010, 20(11): 1380-1388.
[14] DELEHEDDE M, DEVENYNS L, MAURAGE C A, et al. Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan[J]. Int J Cell Biol, 2013, 2013: 705027.
[15] BAGHY K, TÁTRAI P, REGŐS E, et al. Proteoglycans in liver cancer[J]. World J Gastroenterol, 2016, 22(1): 379-393.
[16] LIN L Y, YEH Y C, CHU C H, et al. Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors[J]. Medicine (Baltimore), 2017, 96(41): e8262.
[17] ORBEGOZO D, RAHMANIA L, IRAZABAL M, et al. Endocan as an early biomarker of severity in patients with acute respiratory distress syndrome[J]. Ann Intensive Care, 2017, 7(1): 93.
[18] MIHAJLOVIC D M, LENDAK D F, BRKIC S V, et al. Endocan is useful biomarker of survival and severity in sepsis [J]. Microvasc Res, 2014, 93:92-97.
[19] TANG L, ZHAO Y, WANG D, et al. Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome[J]. Mediators Inflamm, 2014, 2014: 625180.
[20] MIKKELSEN M E, SHAH C V, SCHERPEREEL A, et al. Lower serum endocan levels are associated with the development of acute lung injury after major trauma[J]. J Crit Care, 2012, 27(5): 522.e11-e17. |
|
|
|